Pancreatic Cancer Clinical Trial

- The folks at Hoffmann-La Roche are studying Pancreatic Cancer in individuals ages 18 years and older. This clinical trial is slated to start March 2012 and is expected to end circa March 2015.

888-662-6728 (U.S. Only)
Reference Study ID Number: ML23024
Overall Study Contact Info
StatusName Contact Phone
RecruitingReference Study ID Number: ML23024 (U.S. Only)

This study is officially titled, "Impact on Survival of Cutaneous Reactions in Erlotinib Plus Gemcitabine Treated Patients With Metastatic Pancreatic Cancer Under Conditions of Daily Routine Practice."


K”ln, Germany - Recruiting

For more study details, please visit this link to record, which is the source of this webpage.